Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACV-VAL: Valacyclovir vs Acyclovir for HIV-1 Suppression in Co-infected Persons
NCT01026454Phase 4Completed
- Sponsor
- University of Washington
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of valaciclovir in human immunodeficiency virus infection (HIV), herpes simplex virus infection, sponsored by University of Washington. Started Feb 2010; status: completed.
02
Drugs
valaciclovir
03
Conditions
human immunodeficiency virus infection (HIV)herpes simplex virus infection
Beyond the preview
Go deeper on NCT01026454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026454.